Teligent, Inc. Announces Adjournment of Special Meeting of Stockholders
25 Novembre 2020 - 6:00PM
Teligent, Inc. (Nasdaq: TLGT), a New Jersey-based specialty generic
pharmaceutical company (the “Company”), announced today that its
Special Meeting of Stockholders, scheduled for October 22, 2020,
adjourned to November 11, 2020 and then to November 25, 2020, was
convened and adjourned without any business being conducted due to
the fact that a quorum was not achieved on the proposals to be
approved. Stockholders have thus far strongly supported the
proposals. At the time the meeting was convened, approximately
96.49% of the shares that had been voted had been voted in favor of
the proposals. However, since holders of only 47.46% of the
outstanding shares submitted proxies to vote, the necessary quorum
of a majority of the outstanding shares was not reached. The
Company is adjourning the meeting in order to solicit additional
votes to meet the quorum requirement; as of 10:00 am today the
Company requires an additional 140,077 shares to vote in order to
reach the required quorum. The Company requests that any
stockholder who has not yet voted do so as promptly as possible in
order to avoid additional delays and expense
The Special Meeting will be reconvened at 10:00
a.m. Eastern time on December 16, 2020 to allow more opportunity
for stockholders to vote on the proposals described in the
Company’s definitive proxy statement filed with the Securities and
Exchange Commission (the “SEC”) on September 9, 2020. Stockholders
will be able to attend the rescheduled Special Meeting virtually by
visiting www.virtualshareholdermeeting.com/TLGT2020SM.
The record date for determining stockholders
eligible to vote on the proposals at the Special Meeting remains
September 4, 2020.
The Company strongly encourages any eligible
stockholder that has not yet voted their shares, or provided voting
instructions to their broker or other record holder, to do so
promptly. No action is required by any stockholder who has
previously delivered a proxy and who does not wish to revoke or
change that proxy. Shares may be voted via the Internet, by
telephone and by mail. For questions relating to the voting of
shares or to request additional or misplaced proxy voting
materials, contact the Company’s proxy solicitor: MacKenzie
Partners, Inc. TOLL‐FREE, at 1‐800-322-2885 or COLLECT at
1-212-929-5500 or via email at proxy@mackenziepartners.com.
YOUR PARTICIPATION IS IMPORTANT – PLEASE
VOTE TODAY
A copy of the Company’s proxy statement as
previously filed with the SEC is available at no charge on the SEC
website at www.sec.gov. In addition, copies of the proxy
statement and other documents may be obtained free of charge by
accessing the Company’s website at www.teligent.com or by
contacting the Company’s Corporate Secretary at (856) 776-4632, via
email at InvestorsRelations@teligent.com or by mail to Corporate
Secretary, Teligent, Inc., 105 Lincoln Avenue, Buena, NJ 08310.
Additional Information
This communication may be deemed to be
solicitation material. On September 9, 2020, the Company filed a
definitive proxy statement with the SEC in connection with the
Special Meeting. STOCKHOLDERS ARE URGED TO READ CAREFULLY AND IN
THEIR ENTIRETY THE PROXY STATEMENT AND ANY OTHER SOLICITING
MATERIALS THAT ARE FILED WITH THE SEC WHEN THEY BECOME AVAILABLE
BECAUSE THESE DOCUMENTS CONTAIN IMPORTANT INFORMATION ABOUT THE
COMPANY AND THE PROPOSALS TO BE VOTED UPON. The Company’s proxy
statement and any other solicitation materials filed by the Company
with the SEC can be obtained free of charge at the SEC’s website at
www.sec.gov and at the investor relations section of the Company’s
website at www.teligent.com. The Company, its directors and certain
of its officers and employees will be participants in the
solicitation of proxies from stockholders in respect of the Special
Meeting. The Company has also engaged MacKenzie Partners to aid in
the solicitation of proxies. Detailed information regarding the
identity of the participants, and their respective interests in the
Company by security holdings or otherwise, are set forth in the
definitive proxy statement for the Special Meeting. The contents of
the websites referenced above are not deemed to be incorporated by
reference into the proxy statement.
Forward-Looking Statements
This press release includes “forward-looking
statements” that are intended to qualify for the safe harbors from
liability provided by Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as
amended. All statements other than statements of historical
facts are statements that could be deemed forward-looking. These
statements are based on current expectations, estimates, forecasts
and projections about the Company’s business and the industry in
which the Company operates and the beliefs and assumptions of the
Company’s management. Forward-looking statements can be identified
by the use of words such as “will,” “may,” “could,” “should,”
“would,” “believe,” “depends,” “expect,” “goal,” “anticipate,”
“forecast,” “project,” “future,” “intend,” “plan,” “estimate,”
“target,” “indicate,” “outlook,” and similar expressions of future
intent or the negative of such terms. Forward-looking statements
are neither historical facts nor assurances of future performance.
Instead, these forward-looking statements are based on
management’s current beliefs, expectations and assumptions and are
subject to risks and uncertainties. These statements are based
on the Company’s current beliefs or expectations and are inherently
subject to various risks and uncertainties, including those set
forth under the caption “Risk Factors” in the Company’s most recent
Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and
other periodic reports the Company files with the Securities and
Exchange Commission. Additionally, many of these risks and
uncertainties are currently amplified by and will continue to be
amplified by, or in the future may be amplified by, the COVID-19
outbreak and the effects thereof on the Company’s future
performance and results of operations. It is not possible to
predict or identify all such risks. There may be additional risks
that the Company considers immaterial or which are unknown. You
should not rely upon forward-looking statements as predictions of
future events. The forward-looking statements included in
this press release speak only as of the date hereof and, subject to
any continuing obligations under applicable law or any relevant
stock exchange rules, we expressly disclaim any obligation to
disseminate, after the date of this document, any updates or
revisions to any such forward-looking statements to reflect any
change in expectations or events, conditions or circumstances on
which any such statements are based.
Contact: Philip K. Yachmetz Teligent, Inc. (856)
776-4632 www.teligent.com
Teligent (NASDAQ:TLGT)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
Teligent (NASDAQ:TLGT)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024